Expertise in
7
conditions

Dr. Joel Wirth

Pulmonary Medicine
Chest Medicine Associates PA
100 Foden Rd Ste 103, 
South Portland, ME 
Expertise in
7
conditions
Chest Medicine Associates PA
100 Foden Rd Ste 103, 
South Portland, ME 

Overview

Joel Wirth is a Pulmonary Medicine provider in South Portland, Maine. Dr. Wirth is highly rated in 7 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Cholesterol Pneumonia, and Lung Metastases.

His clinical research consists of co-authoring 7 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Pulmonary Medicine

Licenses

Internal Medicine in ME

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Martin's Point Generations
  • MEDICARE MAPD
  • OTHER MEDICARE
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 1 Less Insurance Carrier -

Locations

Chest Medicine Associates PA
100 Foden Rd Ste 103, South Portland, ME 04106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: February 06, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Drug
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

7 Total Publications

Progressive Pericardial Effusions (PEF) in Patients With Pulmonary Arterial Hypertension (PAH) Taking Sotatercept-Association With Pre-Existing Pericardial Effusion.
Progressive Pericardial Effusions (PEF) in Patients With Pulmonary Arterial Hypertension (PAH) Taking Sotatercept-Association With Pre-Existing Pericardial Effusion.
Journal: Pulmonary circulation
Published: September 15, 2025
Similar Doctors
Expertise in
12
conditions
Dr. Jennifer Palminteri
Pulmonary Medicine
Expertise in
12
conditions
Dr. Jennifer Palminteri
Pulmonary Medicine

Chest Medicine Associates PA

100 Foden Rd Ste 103, 
South Portland, ME 
 (2.1 miles away)
207-828-1122
Languages Spoken:
English
See accepted insurances

Jennifer Palminteri is a Pulmonary Medicine provider in South Portland, Maine. Dr. Palminteri is highly rated in 12 conditions, according to our data. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Cholesterol Pneumonia, and Lung Metastases.

Expertise in
15
conditions
Dr. Paul Laprad
Pulmonary Medicine
Expertise in
15
conditions
Dr. Paul Laprad
Pulmonary Medicine

Mid Coast Medical Group-Pulmonology Critical Care And Sleep Medicine

121 Medical Center Dr Ste 3300, 
Brunswick, ME 
 (25.2 miles away)
207-373-6490
Languages Spoken:
English

Paul Laprad is a Pulmonary Medicine provider in Brunswick, Maine. Dr. Laprad is highly rated in 15 conditions, according to our data. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Chronic Cough, and Asthma in Children.

Expertise in
31
conditions
Dr. Sanjay Godara
Pulmonary Medicine
Expertise in
31
conditions
Dr. Sanjay Godara
Pulmonary Medicine

Pulmonary Associates - Portsmouth

155 Borthwick Ave Ste 301E, 
Portsmouth, NH 
 (46.1 miles away)
Languages Spoken:
English
See accepted insurances

Sanjay Godara is a Pulmonary Medicine provider in Portsmouth, New Hampshire. Dr. Godara is highly rated in 31 conditions, according to our data. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Acute Interstitial Pneumonia, and Emphysema.

Frequently Asked Questions about Dr. Joel Wirth

How do I make an appointment with Dr. Joel Wirth?

You can book an appointment with Dr. Joel Wirth by calling their office at 207-828-1122. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Joel Wirth a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joel Wirth is classified as an Distinguished expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Joel Wirth specialize in?

While Dr. Joel Wirth is a Pulmonary Medicine, they have specific expertise in Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, and Cholesterol Pneumonia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Joel Wirth participate in research or clinical trials?

Yes. Dr. Joel Wirth has published 7 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. Joel Wirth's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Joel Wirth accept my insurance?

Dr. Joel Wirth accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 207-828-1122 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wirth's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile